The Cost of Care Associated with Microvascular Free Tissue Transfer by Anatomical Region: A Time-Driven Activity-Based Model

Abstract

Background Microvascular free tissue transfer (FTT) is a reliable method for reconstruction of complex soft tissue defects. The goal of this study was to utilize time-driven activity-based cost (TDABC) accounting to measure the total cost of care of FTT and identify modifiable cost drivers.

Methods A retrospective review was performed on patients requiring FTT at a single, level-I academic trauma center from 2013 to 2019. Patient and surgical characteristics were collected, and six prospective FTT cases were observed via TDABC to collect direct and indirect costs of care.

Results When stratified by postoperative stay at intensive care units (ICUs), the average cost of care was $21,840.22, while cases without ICU stay averaged $6,646.61. The most costly category was ICU stay, averaging $8,310.99 (40.9% of nonstratified overall cost). Indirect costs were the second most costly category, averaging $4,388.07 (21.6% of nonstratified overall cost). Overall, 13 of 100 reviewed cases required some form of revision free-flap, increasing cumulative costs to $7,961.34 for cases with non-ICU stay and $22,233.85 for cases with ICU stay, averaging up to $44,074.07 for patients who stayed in the ICU for both procedures. An increase in cumulative cost was also observed within the timeframe of the investigation, with average costs of $8,484.00 in 2013 compared to $45,128 for 2019.

Conclusion Primary drivers for cost in this study were ICU stay and revision/reoperation. Better understanding the cost of FTT allows for cost reduction through the development of new protocols that drive intraoperative efficiency, reduce ICU stays, and optimize outcomes.

Keywords

free tissue transfer (FTT) - time-driven activity-based cost (TDABC) - indirect costs - direct costs

Financial Disclosure Statement

B.P.C. reports a grant from Integra associated with the conduct of the study; outside the submitted work, wife is CEO and founder of CODE Technology.

Publikationsverlauf

Eingereicht: 15. Dezember 2020

Angenommen: 15. Februar 2021

Artikel online veröffentlicht:
15. Juni 2021

• References

• 1 Bakhach J, Abou Ghanem O, Bakhach D, Zgheib E. Early free flap reconstruction of blast injuries with thermal component. Ann Burns Fire Disasters 2017; 30 (04) 303-308
• 2 Townley WA, Urbanska C, Dunn RLR, Khan U. Costs and coding--free-flap reconstruction in lower-limb trauma. Injury 2011; 42 (04) 381-384
• 3 Schusterman MA, Miller MJ, Reece GP, Kroll SS, Marchi M, Goepfert H. A single center's experience with 308 free flaps for repair of head and neck cancer defects. Plast Reconstr Surg 1994; 93 (03) 472-478 , discussion 479–480
• 4 Wax MK, Burkey BB, Bascom D, Rosenthal EL. The role of free tissue transfer in the reconstruction of massive neglected skin cancers of the head and neck. Arch Facial Plast Surg 2003; 5 (06) 479-482
• 5 Fischer MD, Gustilo RB, Varecka TF. The timing of flap coverage, bone-grafting, and intramedullary nailing in patients who have a fracture of the tibial shaft with extensive soft-tissue injury. J Bone Joint Surg Am 1991; 73 (09) 1316-1322
• 6 Heller L, Levin LS. Lower extremity microsurgical reconstruction. Plast Reconstr Surg 2001; 108 (04) 1029-1041 , quiz 1042
• 7 Khouri RK, Shaw WW. Reconstruction of the lower extremity with microvascular free flaps: a 10-year experience with 304 consecutive cases. J Trauma 1989; 29 (08) 1086-1094
• 8 Thornton BP, Rosenblum WJ, Pu LLQ. Reconstruction of limited soft-tissue defect with open tibial fracture in the distal third of the leg: a cost and outcome study. Ann Plast Surg 2005; 54 (03) 276-280
• 9 Byrd HS, Spicer TE, Cierney III G. Management of open tibial fractures. Plast Reconstr Surg 1985; 76 (05) 719-730
• 10 Kwok AC, Agarwal JP. An analysis of free flap failure using the ACS NSQIP database. Does flap site and flap type matter?. Microsurgery 2017; 37 (06) 531-538
• 11 Fischer JP, Wink JD, Nelson JA. et al. A retrospective review of outcomes and flap selection in free tissue transfers for complex lower extremity reconstruction. J Reconstr Microsurg 2013; 29 (06) 407-416
• 12 Shasti M, Jauregui JJ, Malik A, Slobogean G, Eglseder WA, Pensy RA. Magnitude of soft-tissue defect as a predictor of free flap failures: does size matter?. J Orthop Trauma 2017; 31 (12) e412-e417
• 13 Koul AR, Patil RK, Nahar S. Unfavourable results in free tissue transfer. Indian J Plast Surg 2013; 46 (02) 247-255
• 14 Bui DT, Cordeiro PG, Hu QY, Disa JJ, Pusic A, Mehrara BJ. Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg 2007; 119 (07) 2092-2100
• 15 Pohlenz P, Blessmann M, Blake F, Li L, Schmelzle R, Heiland M. Outcome and complications of 540 microvascular free flaps: the Hamburg experience. Clin Oral Investig 2007; 11 (01) 89-92
• 16 Nakatsuka T, Harii K, Asato H. et al. Analytic review of 2372 free flap transfers for head and neck reconstruction following cancer resection. J Reconstr Microsurg 2003; 19 (06) 363-368 , discussion 369
• 17 Fischer JP, Sieber B, Nelson JA. et al. Comprehensive outcome and cost analysis of free tissue transfer for breast reconstruction: an experience with 1303 flaps. Plast Reconstr Surg 2013; 131 (02) 195-203
• 18 Shirley R, Fazekas J, McNally M, Ramsden A. Costs and renumeration of osteomyelitis treatment involving free flaps: implications of return to theatre. J Bone Jt Infect 2018; 3 (01) 15-19
• 19 Keehan SP, Stone DA, Poisal JA. et al. National health expenditure projections, 2016-25: Price increases, aging push sector to 20 percent of economy. Health Aff (Millwood) 2017; 36 (03) 553-563
• 20 Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev 2004; 82 (11) 131-138 , 150
• 21 Parikh HR, O'Hara N, Levy JF, Cunningham BP. Value Denominator: The Fundamentals of Costing for Orthopaedic Surgeons. J Orthop Trauma 2019; 33 (S, suppl 7): S56-S61
• 22 Donovan CJ, Hopkins M, Kimmel BM, Koberna S, Montie CA. How Cleveland Clinic used TDABC to improve value. Healthc Financ Manage 2014; 68 (06) 84-88
• 23 Akhavan S, Ward L, Bozic KJ. Time-driven activity-based costing more accurately reflects costs in arthroplasty surgery. Clin Orthop Relat Res 2016; 474 (01) 8-15
• 24 Martin JA, Mayhew CR, Morris AJ, Bader AM, Tsai MH, Urman RD. Using time-driven activity-based costing as a key component of the value platform: a pilot analysis of colonoscopy, aortic valve replacement and carpal tunnel release procedures. J Clin Med Res 2018; 10 (04) 314-320
• 25 McCreary DL, White M, Vang S, Plowman B, Cunningham BP. Time-driven activity-based costing in fracture care: is this a more accurate way to prepare for alternative payment models?. J Orthop Trauma 2018; 32 (07) 344-348
• 26 McCreary DL, Dugarte AJ, Vang S. et al. Patient-level value analysis: an innovative approach to optimize care delivery. J Orthop Trauma 2019; 33 (S, suppl 7): S49-S52
• 27 White M, Parikh HR, Wise KL, Vang S, Ward CM, Cunningham B. Cost savings of carpal tunnel release performed in-clinic compared to an ambulatory surgery center: time-driven activity-based costing. J Hand Surg Am 2018; 43 (09) S9
• 28 Porter ME. What is value in health care?. N Engl J Med 2010; 363 (26) 2477-2481